WHO - Repacholi INFORMATION FOR GENERAL PUBLIC
WHO to develop a general fact sheet that includes the following points: - range of symptoms of IEI - no attribution of causality to EMF - do not include prevalence of EHS but rather prevalence of the different symptoms (and longstanding history of these) in general population - do warn against commercial products to shield against EMF - discourage measurements in homes - exclude underlying somatic disease by usual physical examination - no proof of any correlation between these symptoms and later diseases - reminder of basic physics (NIR vs. IR, etc) - recovery is certainly possible without taking drastic measures - stress due to introduction of new technologies - need for coping strategies
WHO - Repacholi
INFORMATION FOR PHYSICIANS
- Information regarding ill-defined symptoms and undifferentiated illness should be included in post-graduate training - Experts should develop an international protocol for physicians that includes current diagnosis and treatment information - National governments should develop tailored information for medical practitioners
WHO - Repacholi
ADVICE TO GOVERNMENTS
Governments need to put the issue of IEI into their general risk communication strategies. They also need to address the following issues: - Patients have real symptoms, some of which are attributed to EMF, but there is no scientific evidence of causal link, therefore no grounds to use IEI as a diagnostic classification for handicap status. But symptoms could be used as a classification. - No indication that lowering the limits would reduce the prevalence of symptoms attributed to EMF - Discourage measurements in homes - Develop appropriate interaction with self-help groups - Anticipate problems with new technologies, and provide balanced information, promote dialogue. Note different attitude taken for new pharmaceuticals, both before introduction and post-marketing surveillance. Possible role for complaints registers?
Informant: Dr. Claus Scheingraber
The WHO EMF Charade Continues - Time To Stop the WHO Charade
http://omega.twoday.net/stories/819270/
http://omega.twoday.net/search?q=Repacholi
WHO - Repacholi
INFORMATION FOR PHYSICIANS
- Information regarding ill-defined symptoms and undifferentiated illness should be included in post-graduate training - Experts should develop an international protocol for physicians that includes current diagnosis and treatment information - National governments should develop tailored information for medical practitioners
WHO - Repacholi
ADVICE TO GOVERNMENTS
Governments need to put the issue of IEI into their general risk communication strategies. They also need to address the following issues: - Patients have real symptoms, some of which are attributed to EMF, but there is no scientific evidence of causal link, therefore no grounds to use IEI as a diagnostic classification for handicap status. But symptoms could be used as a classification. - No indication that lowering the limits would reduce the prevalence of symptoms attributed to EMF - Discourage measurements in homes - Develop appropriate interaction with self-help groups - Anticipate problems with new technologies, and provide balanced information, promote dialogue. Note different attitude taken for new pharmaceuticals, both before introduction and post-marketing surveillance. Possible role for complaints registers?
Informant: Dr. Claus Scheingraber
The WHO EMF Charade Continues - Time To Stop the WHO Charade
http://omega.twoday.net/stories/819270/
http://omega.twoday.net/search?q=Repacholi
Starmail - 12. Jul, 23:30
